Metastasis-Directed Stereotactic Body Radiation Therapy in Oligometastatic and Oligoprogressive Solid Malignancy: Outcomes and Effect on Systemic Treatment
SBRT is effective and safe for treating OM and OP solid cancers, prolonging FISST and potentially delaying systemic treatments, particularly in settings with limited access to advanced therapies.
Authors
- Ayah Erjan (ORCID: https://orcid.org/0000-0002-1567-3182)
- Sara Mheid (ORCID: https://orcid.org/0000-0003-4545-464X)
- Fawzi Abuhijla (ORCID: https://orcid.org/0000-0002-7264-6789)
- Issa Mohamad (ORCID: https://orcid.org/0000-0003-0153-9131)
- Hikmat Abdel‐Razeq (ORCID: https://orcid.org/0000-0003-2833-6051)
- Wafa Asha (ORCID: https://orcid.org/0000-0002-1046-770X)
- Baha’ Sharaf (ORCID: https://orcid.org/0000-0003-4368-1224)
- Abdulla Alzibdeh (ORCID: https://orcid.org/0000-0002-4962-8398)
- Soha Ahmed (ORCID: https://orcid.org/0000-0003-2450-0563)
- Shatha Abu Taha
- Mohamed Qambar
- Jamal Khader (ORCID: https://orcid.org/0009-0007-3747-1067)
- Abdelatif Al Mousa
- Anoud Alnsour
- Lina Wahbeh
Institutions
- Suez University (EG)
- King Hussein Cancer Center (JO)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1200/go-25-00004
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00